Phospholipase D meets Wnt signaling: A new target for cancer therapy

Cancer Research

Volumn 71, Issue 2, 2011, Pages 293-297

  Kang, Dong Woo ^a   Choi, Kang Yell ^b   Min, Do Sik ^b  

^a Pusan National University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; CYTOKERATIN 17; CYTOKERATIN 5; GASTRIN; GELATINASE A; GELATINASE B; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITOR OF APOPTOSIS PROTEIN; LYSOPHOSPHATIDIC ACID; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL MYRISTATE; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; SHORT HAIRPIN RNA; SURVIVIN; T CELL FACTOR PROTEIN; UNINDEXED DRUG; WNT3A PROTEIN;

AMPLITUDE MODULATION; CANCER GROWTH; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; COLORECTAL CANCER; DNA FLANKING REGION; ENZYME POLYMORPHISM; HUMAN; ISOENZYME ANALYSIS; NEOPLASM; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR VOLUME;

ANIMALS; BETA CATENIN; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 78751480479     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2463     Document Type: Review

References (35)

1. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
2. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51.
3. Huang P, Frohman MA. The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 2007;11:707-16.
4. Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min DS. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/betacatenin/ TCF signaling axis. Cancer Res 2010;70:4233-42.
5. Kang DW, Min DS. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells. PLoS ONE 2010;5: e12109.
6. Su W, Chen Q, Frohman MA. Targeting phospholipase D with smallmolecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol 2009;5:1477-86.
7. Min DS, Kwon TK, Park WS, Chang JS, Park SK, Ahn BH, et al. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 2001;22:1641-7.
8. Knoepp SM, Chahal MS, Xie Y, Zhang Z, Brauner DJ, Hallman MA, et al. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells. Mol Pharmacol 2008;74:574-84.
9. Gozgit JM, Pentecost BT, Marconi SA, Ricketts-Loriaux RSJ, Otis CN, Arcaro KF. PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas. Br J Cancer 2007;97:809-17.
10. Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 2007;9:706-12.
11. Hancock JF. PA promoted to manager. Nat Cell Biol 2007;9:615-7.
12. Foster DA. Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells. Biochim Biophys Acta 2009;1791: 949-55.
13. Kwun HJ, Lee JH, Min DS, Jang KL. Transcriptional repression of cyclin-dependent kinase inhibitor p21 gene by phospholipase D1 and D2. FEBS Lett 2003;544:38-44.
14. Kim J, Lee YH, Kwon TK, Chang JS, Chung KC, Min DS. Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10. Cancer Res 2006;66:784-93.
15. Jang YH, Ahn BH, Namkoong S, Kim YM, Jin JK, Kim YS, et al. Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes. Cell Signal 2008;20:2198-207.
16. Zheng Y, Rodrik V, Toschi A, Shi M, Hui L, Shen Y, et al. Phospholipase D couples survival and migration signals in stress response of human cancer cells. J Biol Chem 2006;281:15862-8.
17. Kang DW, Park MH, Lee YJ, Kim HS, Lindsley CW, Alex Brown H, et al. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Int J Cancer 2010. Epub 2010 Apr 19.
18. Kim SY, Ahn BH, Min KJ, Lee YH, Joe EH, Min DS, et al. Isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells. J Biol Chem 2004;279:38125-33.
19. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, et al. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 2009;5:1008-17.
20. Su W, Yeku O, Olepu S, Genna A, Park JS, Ren H, et al. 5-Fluoro-2- indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol 2009;75:437-46.
21. Kang DW, Park MH, Lee YJ, Kim HS, Kwon TK, Park WS, et al. Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells. J Biol Chem 2008;283:4094-104.
22. Kang DW, Min DS. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkB signaling pathway and enhances invasion of breast cancer cells. Cancer Lett 2010;294:125-33.
23. Gao S, Murakami M, Ito H, Furuhata A, Yoshida K, Tagawa Y, et al. Mutated ras induced PLD1 gene expression through increased Sp1 transcription factor. Nagoya J Med Sci 2009;71:127-36.
24. Kikuchi R, Murakami M, Sobue S, Iwasaki T, Hagiwara K, Takagi A, et al. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 50 promoter. Oncogene 2007;26:1802-10.
25. Song DH, Kaufman JC, Borodyansky L, Albanese C, Pestell RG, Wolfe MM. Gastrin stabilises beta-catenin protein in mouse colorectal cancer cells. Br J Cancer 2005;92:1581-7.
26. Katoh M, Katoh M. Cross-talk of WNT and FGF signaling pathways at GSK3b to regulate β-catenin and SNAIL signaling cascades. Cancer Biol Ther 2006;5:1059-64.
27. Danilkovitch-Miagkova A, Miagkov A, Skeel A, Nakaigawa N, Zbar B, Leonard EJ. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the β-catenin pathway. Mol Cell Biol 2001;21:5857-68.
28. Buongiorno P, Pethe VV, Charames GS, Esufali S, Bapat B. Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wntresponsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells. Mol Cancer 2008;7:73.
29. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, et al. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex. Cell 2002;109:47-60.
30. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008;455:547-51.
31. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810.
32. Takemaru K, Yamaguchi S, Lee YS, Zhang Y, Carthew RW, Moon RT. Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/ Wingless pathway. Nature 2003;422:905-9.
33. Liu J, Wang H, Zuo Y, Farmer SR. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol Cell Biol 2006;26:5827-37.
34. Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM, Burgering BM. Interaction of FOXO with beta-catenin inhibits betacatenin/ T cell factor activity. J Biol Chem 2008;283:9224-30.
35. Miravet S, Piedra J, Miro F, Itarte E, García de Herreros A, Duñach M. The transcriptional factor Tcf-4 contains different binding sites for β-catenin and plakoglobin. J Biol Chem 2002;277:1884-91.